A Qualitative Study of National Perspectives on Advancing Social Prescribing Using Co-Design in Canada.

Autor: Saragosa M; Science of Care Institute, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada.; Institute of Health Policy, Evaluation and Management, University of Toronto, Toronto, Ontario, Canada., Mulligan K; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Hsiung S; Canadian Institute for Social Prescribing, Canadian Red Cross, Toronto, Ontario, Canada., Biswas S; Canadian Institute for Social Prescribing, Canadian Red Cross, Toronto, Ontario, Canada., Card K; Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada., Hébert PC; Bruyère Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Welch V; Bruyère Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Nelson MLA; Science of Care Institute, Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada.; Institute of Health Policy, Evaluation and Management, University of Toronto, Toronto, Ontario, Canada.
Jazyk: angličtina
Zdroj: Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2024 Aug; Vol. 27 (4), pp. e14144.
DOI: 10.1111/hex.14144
Abstrakt: Introduction: Social prescribing offers a formal pathway of connecting patients in the health system with sources of support within the community to help improve their health and well-being. Since its launch in March 2022, the Canadian Institute for Social Prescribing has acted as a collective impact network to identify, connect and build upon established social prescribing initiatives using a co-design methodology. The institute received input from a participant advisory council, co-design partners and several communities of interest groups. This study aimed to describe the perceptions of the Canadian Institute for Social Prescribing's role in advancing social prescribing using a co-design approach and the barriers and facilitators to implementing social prescribing in Canada.
Methods: We used a qualitative descriptive study design, document analysis, participant observation and semi-structured individual interviews (n = 7) with members of the Canadian Institute for Social Prescribing co-design group and the institute's leadership. We also analysed documents, field notes and transcripts using codebook thematic analysis.
Results: Four themes were developed representing the facilitators of implementing the Canadian Institute for Social Prescribing to support social prescribing: Creating relational mechanisms (i.e., partnerships and connections), Bringing awareness to social prescribing and contributing to the evidence (i.e., values and beliefs), Addressing systemic conditions (i.e., having a common language for social prescribing and organizing the community health sector) and Enabling funding and policy to drive social prescribing initiatives (i.e., shifting evidence into policy and securing sustainable funding).
Conclusion: Participants' reflections on the co-design process demonstrated that the Canadian Institute for Social Prescribing development provided networking opportunities and shared resources relevant to social prescribing. Co-design efforts also fostered relational and informational support, which laid the necessary groundwork in Canada to overcome the complex interplay between the macro- and micro-level settings in which social prescribing is practiced.
Patient or Public Contribution: The interviews and observations involved participants with lived experience of delivering, receiving or advocating for social prescribing.
(© 2024 The Author(s). Health Expectations published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje